According to IHS in the Pharma Letter, European government price controls have hit drugmakers pocket books. Further, the effect is seen with both brand name and generic producers. This "recession proof" industry is -- well --
“Nowhere to hide,” says IHS, as Europe's austerity measures impact drug firms - Pharma Letter.
Unrecession Proof.
Posted by Bruce Lehr August 12th 2010.


Comments